Paula Lapinski, MD
MOHS-Micrographic Surgery · Lombard, ILNPI 1437262482
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $234 of the $264 with a category attached, or 88.7%. It is spread thinly across 11 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $142 and has fallen 78.3% since, to $31 in 2023. That places this record below the midpoint for mohs-micrographic surgery clinicians in IL, where the typical reported total is $1,595.
Across 14 payments — averaging $18.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$44
- Mentor Worldwide LLC$34
- Genentech USA, Inc.$33
- Mayne Pharma Commercial LLC$29
- Galderma Laboratories, L.p.$24
- Sandoz$22
- plus $78 from 5 others
What the payments were for
- Speaking & faculty fees$155%
- Food & beverage$23489%
- Education$156%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 3 | $44 |
| Mentor Worldwide LLC | 1 | $34 |
| Genentech USA, Inc. | 2 | $33 |
| Mayne Pharma Commercial LLC | 1 | $29 |
| Galderma Laboratories, L.p. | 1 | $24 |
| Sandoz | 1 | $22 |
| Tactile Systems Technology Inc | 1 | $20 |
| Boehringer Ingelheim | 1 | $16 |
| Pfizer | 1 | $15 |
| Merck | 1 | $14 |
| Sun Pharmaceutical Industries Inc. | 1 | $13 |
How this compares
$264 in reported general payments places this provider in the 20th percentile of 40 mohs-micrographic surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 29 | $108,246 |
| Clobetasol Propionate | 25 | $1,250 |
| Fluorouracil | 11 | $908 |
| Triamcinolone Acetonide | 50 | $690 |
| MethotrexateMethotrexate Sodium | 19 | $284 |
| Hydrocortisone | 11 | $264 |
| Doxycycline Hyclate | 13 | $214 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Lombard
- Vanessa LichonLombard$547
- Scott ZahnerHinsdale$55K
- Melanie ZahnerHinsdale$23K
- Kelly ParkNorthbrook$11K
- Owen KramerElmhurst$10K
- Todd JohnsonChicago$10K
- Simon YooChicago$10K
- Jeffrey McKennaCharleston$10K
- Daniel SchlessingerChicago$8K
- Aleksandar KrunicChicago$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.